Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Daniel E. Weiner"'
Autor:
Abhijit V. Kshirsagar, Daniel E. Weiner, Mallika L. Mendu, Frank Liu, Susie Q. Lew, Terrence J. O’Neil, Scott D. Bieber, David L. White, Jonathan Zimmerman, Sumit Mohan
Publikováno v:
Clin J Am Soc Nephrol
Contemporary nephrology practice is heavily weighted toward in-center hemodialysis, reflective of decisions on infrastructure and personnel in response to decades of policy. The Advancing American Kidney Health initiative seeks to transform care for
Autor:
Yang Yang, Daniel E. Weiner, Robert I. Lynn, Anthony J. Bleyer, Arnold L. Silva, Glenn M. Chertow, Geoffrey A. Block, David P. Rosenbaum
Publikováno v:
Kidney360
BACKGROUND: Treating hyperphosphatemia is a tenet of dialysis care. This trial assessed the safety and efficacy of tenapanor for the management of hyperphosphatemia. METHODS: In this 52-week phase 3 study (NCT03427125), participants receiving mainten
Autor:
Mark J, Sarnak, Bourne L, Auguste, Edwina, Brown, Alexander R, Chang, Glenn M, Chertow, Mary, Hannan, Charles A, Herzog, Annie-Claire, Nadeau-Fredette, Wai Hong Wilson, Tang, Angela Yee-Moon, Wang, Daniel E, Weiner, Christopher T, Chan
Publikováno v:
Circulation. 146
Cardiovascular disease is the leading cause of morbidity and mortality in patients with end-stage kidney disease. Currently, thrice-weekly in-center hemodialysis for 3 to 5 hours per session is the most common therapy worldwide for patients with trea
Autor:
John B. Wong, Keren Ladin, Susan Koch-Weser, Dena E. Rifkin, Ana Rossi, Elisa J. Gordon, Tamara Isakova, Noah D'Arcangelo, Daniel E. Weiner, Isabel Neckermann
Publikováno v:
J Am Soc Nephrol
Background Older patients with advanced CKD are at high risk for serious complications and death, yet few discuss advance care planning (ACP) with their kidney clinicians. Examining barriers and facilitators to ACP among such patients might help iden
Autor:
Mallika L. Mendu, Daniel E. Weiner
Publikováno v:
American Journal of Kidney Diseases. 76:720-730
Kidney care in the United States is highly regulated, reflecting the dominance of Medicare as the primary payer for dialysis since inclusion of the end-stage renal disease (ESRD) benefit into payment policy in 1973. In the ensuing decades, bundled pa
Autor:
Stephen R Rapp, Sarah A Gaussoin, Bonnie C Sachs, Gordon Chelune, Mark A Supiano, Alan J Lerner, Virginia G Wadley, Valarie M Wilson, Lawrence J Fine, Jeff C Whittle, Alexander P Auchus, Srinivasan Beddhu, Dan R Berlowitz, Adam P Bress, Karen C Johnson, Marie Krousel-Wood, Jennifer Martindale-Adams, Eliza C Miller, Dena E Rifkin, Joni K Snyder, Leonardo Tamariz, Dawn F Wolfgram, Maryjo L Cleveland, Mia Yang, Linda O Nichols, Robert Nick Bryan, David M Reboussin, Jeff D Williamson, Nicholas M Pajewski, Alfred K Cheung, Laura H Coker, Michael G Crowe, William C Cushman, Jeffery A Cutler, Christos Davatzikos, Lisa Desiderio, Jimit Doshi, Guray Erus, Darrin Harris, Paul L Kimmel, Manjula K Tamura, Lenore J Launer, Cora E Lewis, Claudia S Moy, Suzanne Oparil, Paula K Ogrocki, Mahboob Rahman, Ilya M Nasrallah, Michael V Rocco, Kaycee M Sink, Carolyn H Still, Jennifer Walker, Daniel E Weiner, Paul K Whelton, Valerie M Wilson, Nancy Woolard, Jackson T Wright, Clinton B Wright, R Nick Bryan
Publikováno v:
The Lancet Neurology. 19:899-907
Summary Background Results from the Systolic Blood Pressure Intervention Trial (SPRINT) showed that intensive control of systolic blood pressure significantly reduced the occurrence of mild cognitive impairment, but not probable dementia. We investig
Autor:
Patti L. Ephraim, Alyssa Platt, Daniel E. Weiner, Jonathan Wilson, Jane F. Pendergast, L. Ebony Boulware, Julia J. Scialla, Angel Chen, Angelina S. Hwang, Rasheeda K. Hall
Publikováno v:
Clin J Am Soc Nephrol
Background and objectives With multiple medications indicated for mineral metabolism, dialysis providers can apply various strategies to achieve target phosphate and parathyroid hormone (PTH) levels. We describe common prescribing patterns and practi
Autor:
Werner Beck, Ha Tran, Angelito A. Bernardo, Luke Falzon, Mengqi Xiao, Line Skoufos, Daniel E. Weiner
Publikováno v:
Clin J Am Soc Nephrol
BACKGROUND AND OBJECTIVES: Expanded hemodialysis therapy enabled by medium cut-off membranes may promote greater clearance of larger middle molecules that comprise putative uremic solutes than conventional high-flux dialysis. This randomized trial ev
Publikováno v:
Clinical Pharmacology and Therapeutics
Most drug labels do not contain dosing recommendations for a significant portion of real-world patients for whom the drug is prescribed. Current label recommendations predominately reflect the population studied in pivotal trials that typically exclu
Publikováno v:
Am J Kidney Dis